News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
856,295 Results
Type
Article (87118)
Company Profile (704)
Press Release (768453)
Multimedia
Podcasts (159)
Webinars (21)
Section
Business (232932)
Career Advice (4136)
Deals (39773)
Drug Delivery (132)
Drug Development (91162)
Employer Resources (200)
FDA (18231)
Job Trends (17378)
News (397086)
Policy (39872)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (127)
Alzheimer's disease (1628)
Antibody-drug conjugate (ADC) (197)
Approvals (18205)
Artificial intelligence (430)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (142)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (45)
Breast cancer (420)
Cancer (3360)
Cardiovascular disease (273)
Career advice (3545)
Career pathing (34)
CAR-T (220)
CDC (43)
Cell therapy (607)
Cervical cancer (27)
Clinical research (74692)
Collaboration (1210)
Company closure (4)
Compensation (806)
Complete response letters (44)
COVID-19 (2926)
CRISPR (71)
C-suite (443)
Cystic fibrosis (128)
Data (3439)
Decentralized trials (2)
Denatured (57)
Depression (88)
Diabetes (396)
Diagnostics (7021)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (197)
Drug pricing (167)
Drug shortages (36)
Duchenne muscular dystrophy (174)
Earnings (98567)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131890)
Executive appointments (938)
FDA (20343)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1080)
Gene editing (154)
Generative AI (42)
Gene therapy (482)
GLP-1 (976)
Government (5324)
Grass and pollen (7)
Guidances (327)
Healthcare (20928)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (201)
Immuno-oncology (17)
Indications (44)
Infectious disease (3135)
Inflammatory bowel disease (173)
Inflation Reduction Act (13)
Influenza (82)
Intellectual property (148)
Interviews (813)
IPO (17913)
IRA (59)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (65)
Layoffs (614)
Leadership (28)
Legal (10142)
Liver cancer (88)
Longevity (12)
Lung cancer (468)
Lymphoma (240)
Machine learning (17)
Management (65)
Manufacturing (517)
MASH (113)
Medical device (14791)
Medtech (14803)
Mergers & acquisitions (22647)
Metabolic disorders (1023)
Multiple sclerosis (108)
NASH (23)
Neurodegenerative disease (168)
Neuropsychiatric disorders (48)
Neuroscience (2464)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (53)
Obesity (516)
Opinion (300)
Ovarian cancer (109)
Pain (139)
Pancreatic cancer (139)
Parkinson's disease (210)
Partnered (27)
Patents (365)
Patient recruitment (225)
Peanut (55)
People (65925)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23038)
Phase II (32427)
Phase III (24419)
Pipeline (2317)
Policy (270)
Postmarket research (3554)
Preclinical (10402)
Press Release (72)
Prostate cancer (163)
Psychedelics (47)
Radiopharmaceuticals (279)
Rare diseases (576)
Real estate (7404)
Recruiting (76)
Regulatory (27501)
Reports (64)
Research institute (2668)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (14)
RSV (62)
Schizophrenia (113)
Series A (179)
Series B (130)
Service/supplier (30)
Sickle cell disease (72)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4313)
State (2)
Stomach cancer (17)
Supply chain (89)
Tariffs (81)
The Weekly (100)
Vaccines (979)
Venture capital (62)
Weight loss (356)
Women's health (54)
Worklife (20)
Date
Today (86)
Last 7 days (493)
Last 30 days (2673)
Last 365 days (34022)
2025 (21834)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (74)
Alaska (7)
Arizona (288)
Arkansas (14)
Asia (50689)
Australia (8906)
California (8500)
Canada (2595)
China (785)
Colorado (362)
Connecticut (380)
Delaware (231)
Europe (116389)
Florida (1272)
Georgia (293)
Hawaii (3)
Idaho (67)
Illinois (775)
India (39)
Indiana (416)
Iowa (19)
Japan (255)
Kansas (120)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1179)
Massachusetts (6459)
Michigan (290)
Minnesota (524)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (95)
New Hampshire (75)
New Jersey (2357)
New Mexico (31)
New York (2332)
North Carolina (1316)
North Dakota (10)
Northern California (3746)
Ohio (271)
Oklahoma (17)
Oregon (49)
Pennsylvania (1802)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (42)
South Dakota (1)
Southern California (3195)
Tennessee (137)
Texas (1333)
United States (31812)
Utah (252)
Virginia (231)
Washington D.C. (81)
Washington State (734)
West Virginia (4)
Wisconsin (89)
There are 856,295 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NervGen Pharma Reports Second Quarter Financial Results and Provides Letter to Shareholders
August 26, 2025
·
14 min read
Press Releases
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
August 26, 2025
·
7 min read
Press Releases
OS Therapies Terminates Equity Line of Credit
August 26, 2025
·
4 min read
Layoff Tracker
LB Pharma Loses Execs Ahead of IPO
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
August 26, 2025
·
190 min read
·
BioSpace Editorial Staff
Obesity
Lilly Plots Path to FDA After Second Phase III Readout for Orforglipron
While Truist Securities analysts said the results from the ATTAIN-2 trial leave “room for competition,” they also pointed to a manufacturing advantage that could unlock a “double-digit billion dollar opportunity” for Eli Lilly.
August 26, 2025
·
2 min read
·
Tristan Manalac
COVID-19
CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup
The MIT professor of management, who already sits on the CDC’s revamped immunization advisory committee, is a known skeptic of vaccines, particularly mRNA technology.
August 26, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Argenx Eyes ‘Broadest Label’ for Vyvgart in Myasthenia Gravis After Positive Phase III Data
Based on new data, argenx expects to file for the expansion of Vyvgart’s label into patients with generalized myasthenia gravis who are negative for antibodies against the AChR marker—an indication William Blair analysts called the broadest option in this disease space.
August 26, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Trump, Kennedy Could Ban COVID-19 Vaccine ‘Within Months’: Report
The White House has denied reports that the government could soon ban COVID-19 vaccines, noting that in the absence of an official announcement, “any discussion about HHS policy should be dismissed as baseless speculation.”
August 26, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Kite Cell Therapy Collaborator Appia Shutters
Appia Bio’s shutdown continues an unfortunate trend this year that has seen biotech closures nearly every month.
August 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Innoviva to Participate in Upcoming September 2025 Investor Conferences
August 26, 2025
·
2 min read
1 of 85,630
Next
